BIOKIT HSV-2 RAPID TEST 3000 28001

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2020-02-10 for BIOKIT HSV-2 RAPID TEST 3000 28001 manufactured by Biokit, Sa.

Event Text Entries

[179382414] Twenty-one blood samples that were (b)(6) for (b)(6) on the diasorin liaison hsv test were submitted to (b)(6) for bio kit test. Six of the samples were biokit (b)(6): the 6 biokit (b)(6) samples were sent for western blot test 4 were wb (b)(6) for (b)(6). I was wb (b)(6) for (b)(6) was wb indeterminate for (b)(6). (b)(6) rate for biokit compared to western blot (run at university of (b)(6)) was 66%. The 6 biokit samples were run at (b)(6). Diasorin liaison is an fda-cleared screening test for (b)(6) by immunoassay. Western blot is the gold standard for confirmation and was run at the university of (b)(6) urology lab.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5092892
MDR Report Key9693750
Date Received2020-02-10
Date Added to Maude2020-02-11
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag0
Product Problem Flag0
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBIOKIT HSV-2 RAPID TEST
Generic NameENZYME LINKED IMMUNOABSORBENT ASSAY, HERPES SIMPLEX VIRUS, NON-SPECIFIC
Product CodeLGC
Date Received2020-02-10
Model Number3000 28001
Lot NumberB31915
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrI
Device Sequence No1
Device Event Key0
ManufacturerBIOKIT, SA


Patients

Patient NumberTreatmentOutcomeDate
10 2020-02-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.